who is not a good candidate for glp 1 GLP-1 Medications Weight Loss: How to Get Started | News Who Should Not Take Wegovy?

(And Why Its Not Just Another Weight Loss Supplement) The wellness industry is saturated with solutions that offer short-lived resultspowders that bloat you, pills that spike your heart rate, and teas that drain water weight without addressing real fat stores

But the gap in clinical outcomes between the two classes may narrow as insulin technology catches up with the incretin-based revolution

Last year, the agency partnered with Genomics England to use the UK Biobank to delve deeper into the risk of pancreatitis among GLP-1 users, to see if there is a genetic factor that elevates the risk

Pierro C, Cook SJ, Foets TC, Bootman MD, Roderick HL

Any new development program would need to address the FDA's 2018 endocrine advisory committee position that GH secretagogues require long-term cardiovascular safety data given IGF-1's association with cancer risk in epidemiologic studies 21